Acceder

Publicaciones - Investigación en Pediatría

Cargando...
Romero-Tapia SJ, Garcia-Marcos L. Global burden of pediatric asthma and rhinitis - what we have recently learned from epidemiology. Curr Opin Allergy Clin Immunol. 2024 Feb 22. doi: 10.1097/ACI.0000000000000975. Online ahead of print. PubMed PMID: 38386768.
AÑO: 2024; IF: 2.8
Garcia-Marcos L. Grand challenges in genetics and epidemiology of allergic diseases: from genome to exposome and back. Front Allergy. 2024 Feb 5;5:1368259. doi: 10.3389/falgy.2024.1368259. eCollection 2024. No abstract available. PubMed PMID: 38375070; PubMed Central PMCID: PMC10875042.
AÑO: 2024
Castelbon Fernandez FJ, Barreda Sanchez M, Arranz Canales E, Hernandez Contreras ME, Solares I, Morales Conejo M, Munoz Cuadrado A, Casado Gomez A, Yebenes Cortes M, Guillen Navarro E. The burden of disease and quality of life in patients with acute hepatic porphyria: COPHASE study. Med Clin (Barc). 2024 Feb 9;162(3):103-111. doi: 10.1016/j.medcli.2023.08.009. Epub 2023 Oct 12. English, Spanish. PubMed PMID: 37838536.
AÑO: 2024; IF: 3.9
Galan Carrillo I, Galbis Martinez L, Martinez V, Roca Merono S, Ramos F, Gonzalez Rodriguez JD, Pinero Fernandez J, Guillen Navarro E. Multidisciplinary management improves the genetic diagnosis of hereditary kidney diseases in the next generation sequencing (NGS) era. Nefrologia (Engl Ed). 2024 Jan-Feb;44(1):69-76. doi: 10.1016/j.nefroe.2024.02.002. Epub 2024 Feb 27. PubMed PMID: 38418364.
AÑO: 2024
Kuter DJ, Bonkovsky HL, Monroy S, Ross G, Guillen-Navarro E, Cappellini MD, Minder AE, Hother-Nielsen O, Ventura P, Jia G, Sweetser MT, Thapar M; ENVISION Investigators. Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial. J Hepatol. 2023 Nov;79(5):1150-1158. doi: 10.1016/j.jhep.2023.06.013. Epub 2023 Jul 20. PubMed PMID: 37479139.
AÑO: 2023; IF: 25.7
Siguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII